阿那莫林有哪几个版本?分别多少钱?

Anamulin is a drug used to treat cancer cachexia. It was developed by Japan's Ono Pharmaceutical and was approved by the US FDA in 2021. There are currently multiple versions on the market, including original drugs and generic drugs, and prices vary depending on the manufacturer and specifications. This article will introduce in detail the version and price of Anamorelin as well as its listing and medical insurance status in the Chinese market to help readers fully understand this drug.

What are the versions of Anamorelin?

It is a drug for treating cancer cachexia. Currently, there are two main versions: original drug and generic drug. The original drug is produced by Ono Pharmaceuticals of Japan, while the generic drugs are mainly produced by manufacturers such as Lucius of Laos. Different versions vary in specifications and prices, but the core ingredient is anamulin hydrochloride.

Original drug version

The original drug is developed and produced by Japan's Ono Pharmaceutical. The brand name is Adlumiz. Its specification is 50mg*100 capsules/box. It is the earliest approved version on the market and has high recognition and clinical data support.

Generic drug version

Generic drugs are mainly produced by manufacturers such as Laos Lucius, with a specification of 50mg*100 tablets/box. Generic drugs are the same as the original drugs in terms of ingredients and dosage forms, but are more affordable and provide patients with more choices.

Whether it is an original drug or a generic drug, patients must strictly follow the doctor's instructions when using it, and pay attention to the authenticity and storage conditions of the drug.

How much do different versions of Anamorelin cost?

The price of Anamorelin varies depending on the version and manufacturer. The following is the price information of the main versions currently on the market.

Original drug price

The original drug Adlumiz produced by Japan's Ono Pharmaceutical has a specification of 50mg*100 capsules/box, and the reference price is about US$463 per box. This version is relatively expensive due to its research and development background and clinical data support.

Price of generic drugs

The generic drugs produced by Lucius in Laos have a specification of 50mg*100 tablets/box, and the reference price is about US$412 per box. The price of generic drugs is more economical than that of brand-name drugs, making them suitable for patients with limited budgets.

Patients must go through formal channels when purchasing to avoid buying fake or inferior drugs, and pay attention to the production date and storage conditions of the drugs.

The marketing and medical insurance status of Anamorelin in China

Anamulin has not yet been officially launched in China, nor has it been included in China's medical insurance catalog. Nonetheless, some generic drugs are already on the market and available to patients through specific channels.

Chinese market status

Since Anamorelin has not been approved for marketing in China, patients who need to use it must purchase it through hospitals, pharmacies or regular medical service institutions in listed countries. When purchasing, they must pay special attention to the authenticity and legality of the drug.

Medical insurance coverage

Anamulin is not included in China’s medical insurance, and patients need to purchase it at their own expense. For patients with limited financial resources, generic drugs may be a more affordable option.

With further research and approval of the drug in China in the future, Anamorelin is expected to provide treatment options for more Chinese patients. Prior to this, patients should carefully choose purchasing channels and follow their doctors’ medication instructions.